type here...

CATEGORIES

Industry News

LATEST

1...111213...24Page 12 of 24

TRENDING

EDITORS CHOICE

Does Pharma Need Independent DNA Oversight?

Robert Turner, Founding Editor -
Our survival as a species could be placed in jeopardy if we don't begin to police treatments that place our DNA in harms way. Oversight is needed.

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Medika Life -
Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

68 Percent of Patients With Mild COVID-19 Get New Diagnosis Within 6 Months

Medika Life -
A worrying number of patients with an initially mild infection of Covid are developing long term conditions and symptoms that require medical attention. CDC suggest up 68 percent of us.

We Have Inadvertently Built Cultural Discrimination Into Our Healthcare Systems

Robert Turner, Founding Editor -
We build and use discriminatory Healthcare Systems. Unintentional by design, these systems propagate inequality in patient care and promote racial disparities.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories